Skip to main content
Friday, October 30, 2026Oct 30

Deborah Levine


Opinion: Why diabetics need to vote

It's amazing that Medicare recipients just gained a cap on what they will pay for insulin. It's incredible considering the pharmaceutical industry's lobbying efforts against any price controls or negotiations. Spearheaded by the Pharmaceutical Research and Manufacturers of America, often known as Pharma, those efforts have been ongoing for years. And in September 2021, it was reported by The Hill that Pharma was launching a seven-figure ad campaign against the proposals moving through Congress to allow negotiation of drug prices.

File photo by Amber Ford of The New York Times / Insulin is shown in in Elyria, Ohio, one Nov. 3, 2021.